Van der Bogt, K.E.A., Sheikh, A.Y., Schrepfer, S., Hoyt, G., Cao, F., Ransohoff, K.J., Swijnenburg, R.-J., Pearl, J., Lee, A., Fischbein, M, Contag, C.H., Robbins, R.C. and Wu, J.C. (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation, 118, S121-S129. doi:10.1161/CIRCULATIONAHA.107.759480

has been cited by the following article:

• TITLE: Hematopoietic stem cells are a critical sub-population of whole bone marrow in the treatment of myocardial infarction

  AUTHORS: Philip Davy, Brienne Walker, Livingston Wong, Richard Allsopp

  KEYWORDS: Hematopoietic Stem Cells; Myocardial Infarction; Transplantation; Cardiac Disease

  JOURNAL NAME: Stem Cell Discovery, Vol.3 No.2, April 23, 2013

  ABSTRACT: Recent studies suggest that whole bone marrow (WBM) derived stem cells may facilitate recovery following myocardial infarction. However, the sub-population of WBM responsible for recovery remains uncertain. By adjusting the abundance of CD34+LinNeg cells in human bone marrow we examined the relative significance of hematopoietic stem cells (HSC) in the recovery of cardiac function in a murine model of induced myocardial infarction. Enrichment of HSC by ~100-fold in WBM transplanted into mice significantly increased recovery of heart function and reduced scar size compared to transplantation of WBM depleted in HSC by ~10-fold (P P P P